OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Promising traditional Chinese medicine for the treatment of cholestatic liver disease process (cholestasis, hepatitis, liver fibrosis, liver cirrhosis)
Chunlei Wei, Jing Qiu, Yuyi Wu, et al.
Journal of Ethnopharmacology (2022) Vol. 297, pp. 115550-115550
Closed Access | Times Cited: 40

Showing 26-50 of 40 citing articles:

Mesenchymal stem cell therapy for liver fibrosis need “partner”: Results based on a meta-analysis of preclinical studies
Yan Xu, Xuesong Wang, Xiaolei Zhou, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 32, pp. 3766-3782
Open Access | Times Cited: 1

Gut microbiota-mediated C-sulfonate metabolism impairs the bioavailability and anti-cholestatic efficacy of andrographolide
Dafu Tang, Wanyu Hu, Bingxuan Fu, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1

Scoparone alleviates nonalcoholic fatty liver disease by modulating the PPARα signaling pathway
Ping Huang, Lili Yang, Tao Liu, et al.
European Journal of Pharmacology (2024) Vol. 984, pp. 177033-177033
Closed Access | Times Cited: 1

Pretreatment of artesunate promoted hepatocyte proliferation by activating the PI3K/Akt/mTOR signaling pathway in mice
LU Chang-you, Xinkai Li, Chao Fang, et al.
Acta Cirúrgica Brasileira (2024) Vol. 39
Open Access | Times Cited: 1

Hepatoprotective efficacy and interventional mechanism of JianPi LiShi YangGan formula in acute-on-chronic liver failure
Jing Li, Qi Huang, Wenfeng Ma, et al.
Journal of Ethnopharmacology (2023) Vol. 318, pp. 116880-116880
Closed Access | Times Cited: 3

Vitexin: A Dietary Flavonoid with Potential Protective Effects Against Liver Diseases
Shu Dai, Ke Fu, Yanfang Liu, et al.
Food Reviews International (2024) Vol. 40, Iss. 10, pp. 3254-3290
Closed Access

Ethnobotanical survey and scientific validation of liver-healing plants in northeastern Morocco
Noureddine Bencheikh, Amine Elbouzidi, Abdellah Baraich, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access

Swertia cincta and its main active ingredients regulate the PPAR-α pathway in anti-cholestatic liver injury
Shuaixia Feng, Jie Tang, Wei Xia, et al.
Journal of Ethnopharmacology (2024), pp. 118956-118956
Closed Access

Chidan Tuihuang Granule Modulates Gut Microbiota to Influence NOD1/RIPK2 Pathway in Cholestatic Liver Injury Recovery
Yuan Chen, Qichao Hu, Wenwen Zhang, et al.
Phytomedicine (2024) Vol. 135, pp. 156164-156164
Closed Access

Correlation Analysis Between Phytochemical Composition and Biological Activities of Artemisia scoparia
Panpan Zhang, Haoyu Wang, Xinyu Xu, et al.
Food Bioscience (2024), pp. 105342-105342
Closed Access

Previous Page - Page 2

Scroll to top